Dr. Christopher Penton,
Icagen, Inc., Tucson, Arizona, USA
Muscle differentiation on laminin-521 is nothing short of spectacular, yielding increased numbers of nuclei per myotube and improved myotube organization. Surprisingly, muscle cells expanded on laminin-521 maintain their ability to differentiate into myotubes after long-term passaging, better resembling differentiation of freshly isolated cells.
Muscle cells grow 2-3 times more rapidly on laminin-521 compared to other substrates. On laminin-521, 90-100% of muscle cells are simultaneously in the cell cycle compared to about 50% or less on other commonly utilized substrates. I believe by attaining uniform expansion it may be possible to reduce selection processes that often plague traditional muscle cell culture.
For drug discovery purposes, laminin-521 allows you to rapidly expand muscle cells into 100 million cells or greater while maintaining excellent differentiation; it’s a win-win."
Dr. David Hay,
MRC Centre for regenarative medicine,
University of Edinburgh, UK
"The use of recombinant laminins in conjunction with our differentiation systems have significantly advanced stem cell derived hepatocyte performance and polarity. Importantly, those processes are now fully defined, and GMP ready, offering exciting prospect for human regenerative medicine”
Prof. Malin Parmar,
Lund University, Sweden
"We have struggled for a number of years to establish a GMP manufacturing process for
generating DA neurons from human embryonic stem cells in order to develop a stem cell
based therapy for Parkinson’s Disease. The recombinant laminins from Biolamina really
made a world of difference! We now routinely use LN521 and EDTA for passaging the
pluripotent stem cells and we have a greater efficiency than ever before. It also turns out
that the DA progenitor cells love to grow on LN111 and after introducing this into our
protocol we now have a high yield, high quality GMP differentiation ready to use”
“ My lab is using BioLamina products and I am encouraging my colleagues to use them too. I’m a fan.
Everyone should use the appropriate laminin!”
Dr. Kevin Hamill, University of Liverpool, UK
Prof. Outi Hovatta
Karolinska Institute, Sweden
"BioLamina's human recombinant laminin-521 is outstanding in supporting human embryonic stem cell growth. In addition, it makes hES cell handling easy because of single-cell passaging with trypsin."
"We at the iPS core at Karolinska Institutet use laminin-521 for derivation and maintenance of our iPS cells. It is reliable, consistent and user-friendly for us and for our customers."
Malin Kele, Sr Lab Manager, iPS Core/Anna Falk lab, Karolinska Institutet, Sweden
Testamonial for LN521:
"To be brief. WOW!"
"I know it sounds wierd, but again, WOW. I wasted so much time on other stuff."
Dr. Yaqub (Jacob) Hanna, Principal Investigator at Weizmann Institute of Science, Israel.
"The beginning of my project required the introduction of fully defined culture conditions for both the self-renewal and subsequent differentiation of human pluripotent stem cells (hPSCs). In conjunction with fully defined media I evaluated the performance of various commercially available matrices for their ability to support hPSC self-renewal. Recombinant laminin-521 (LN521) quickly became my favourite due to reliable passaging outcomes, speed of hPSC growth and the absence of spontaneous differentiation. Following adaptation of 10 clinical-grade human embryonic stem cell lines to this matrix we found no detriment to their genetic stability as seen by SNP array analysis. It is safe to say that with the use of LN521, the culture of human PSCs has become as straight-forward as that of their mouse counterparts.”
Dr. Maurice A. Canham, MRC Centre for regenarative medicine, The University of Edinburgh, UK
LN-521 was used in the report published by Canham et al., The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines, Scientific Reports, 2015
Dr. Mieke Geens
Medical School of the Vrije Universiteit, Belgium
"We have changed our hESC and hiPSC cultures from a MEF-based system to laminin-521 in combination with Nutristem medium. This system allows a more standardized culture, independent of variable batches of MEFs. We experienced that the laminin-521 culture system has a high efficiency and lower labor-intensity when compared to the MEF-based systems. LN521 enabled us to culture our cell lines more flexibly, using only small quantities of cells for routine maintenance of lines and allowing a fast upscaling of cultures when experiments are planned.
Dr. Lynn Yap
Research fellow at DUKE University, Singapore
"Those were the days when laborious preparatory steps were necessary even before the actual passaging of hES cells. Most of my time was utilized to inactivate feeder layers, harvest conditioned media or manual dissection of the undifferentiated pluripotent colonies under a microscope. I also frequently encountered inconsistent results that were possibly due to batch-to-batch variation in the various coating matrices. However, the introduction of BioLaminas laminin-521 makes notoriously difficult hES cells passaging so easy. Today, I passage my cells as single cells without ROCKi in significantly less time and with higher yield. The uniform pluripotent cells means no more tedious manual picking of colonies and gives highly reproducible results"
"Before BioLamina, it was challenging to assess the reactivity of individual laminin isoforms towards cells because it is very difficult to purify laminins from tissues. Using the recombinant and very pure laminins from BioLamina, we could show that vascular isoforms containing the α5 or α4 but not α2 chain support efficient blood platelet adhesion and activation under flow in a process dependent on integrin α6β1, GPVI and the GPIb-VWF axis."
Dr. Mathieu Schaff, INSERM, Université de Strasbourg, France
Different laminin isoforms were used in: "Integrin α6β1 is the Main Receptor for Vascular Laminins and Plays a Role in Platelet Adhesion, Activation and Arterial Thrombosis", published in Circulation, 2013.
"BioLamina's laminin-511 allows mouse ES cells to grow as a monolayer even on glass, which is suitable especially for live imaging."
Dr. Yusuke Miyanari, IGBMC, France
Laminin-511 was used as a growth matrix in Dr. Miyanari study "Control of ground-state pluripotency by allelic regulation of Nanog" published in Nature, 2012.
"Commercial preparations of laminin from other sources tended to be inconsistent mixtures of multiple laminin isoforms. The recombinant laminins from Biolamina allowed us to identify interactions between MCAM and specific isoforms of laminin that may underlay important aspects of T cell biology."
Dr. Kenneth Flanagan, Elan Pharmaceuticals, USA
Laminin-411 was used in Dr. Flanagan's study: "Laminin-411 is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS" published in PLOS ONE, 2012.